$キャッサバ・サイエンシズ(SAVA.US)$New SAVA Update April 25th , 2024 on Clinical Trials. Open-label Study of the Absorption, Metabolism, and Excretion" for SAVA's promising Phase 3 #Alzheimers drug candidate is now complete. - Thanks Archisaurus !
1
1
報告
HolyPotatoe :
So what does that mean to the stock? Doesn’t look like it’s going anywhere?
$キャッサバ・サイエンシズ(SAVA.US)$With another Insider Barry Richard acquiring even more new shares and no one selling. 1900 people are getting help treatments with no side effects, slowing decline and improving cognition. The rest of the world will truly benefit from this treatment very soon with phase 3 trials close to ending
$キャッサバ・サイエンシズ(SAVA.US)$Another Insider Acquiring More Shares. None of the Insiders sold any the stock shares. They continued to add more as we get closer to data Phase 3 trial Readout!!
$キャッサバ・サイエンシズ(SAVA.US)$We all knew this was going to save lives and improve cognition and more families will benefit from SAVA treating Alzheimer’s soon. Very Good News!!!
HolyPotatoe : So what does that mean to the stock? Doesn’t look like it’s going anywhere?